Report Detail

Request for Sample of this report

Chemical & Material Global Follicle Stimulating Hormone Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026

  • RnM3864228
    • |
  • 09 January, 2020
    • |
  • Global
    • |
  • 100 Pages
    • |
  • XYZResearch
    • |
  • Chemical & Material

In this report, global Follicle Stimulating Hormone Market will reach 1494.20 Million USD by the end of 2022 with a CAGR of 0.11%

The global Follicle Stimulating Hormone market was valued at 1486.36 Million USD in 2017 and will reach 1494.20 Million USD by the end of 2022, growing at a CAGR of 0.11% during 2017-2022.

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU.

Follicle Stimulating Hormone can be divided into two categories—Urinary FSH type and Recombinant FSH type. Recombinant FSH type sales market share accounted for the highest proportion, with a figure of 83.66% in 2017, Urinary FSH type account for 16.34%.

The sales market share of global Follicle Stimulating Hormone in Infertility Treatment use and Assisted Reproductive Technology use have been stable year by year, at 83.63% and 16.37% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Follicle Stimulating Hormone in the global market tends to be fixed without great changes. Among them, the Follicle Stimulating Hormone market has the most promising sales prospects in Infertility Treatment use.

XYZ research center data shows that Europe is the biggest contributor to the Follicle Stimulating Hormone revenue market, accounted for 35.28% of the total global market with a revenue of 524.44 million USD in 2017, followed by North America, 26.85% with a revenue of 399.08 million USD.

Merck Serono is the largest company in the global Follicle Stimulating Hormone market, accounted for 59.98% of the revenue market share in 2017, followed by MSD and Livzon, accounted for 24.35% and 5.12% of the revenue market share in 2017. The Follicle Stimulating Hormone industry is not concentrated, these manufacturers range from large multinational corporations to small privately owned companies compete in this industry. The top five manufacturers account for 95.80% of the revenue market.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Follicle Stimulating Hormone for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

Global Follicle Stimulating Hormone market competition by top manufacturers/players, with Follicle Stimulating Hormone sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Recombinant FSH
Urinary FSH
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Follicle Stimulating Hormone for each application, including
Infertility Treatment
Assisted Reproductive Technology

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Follicle Stimulating Hormone Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Recombinant FSH
      • 2.1.2 Urinary FSH
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Recombinant FSH
      • 2.2.2 Urinary FSH

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Infertility Treatment
      • 3.1.2 Assisted Reproductive Technology

    4 Manufacturers Profiles/Analysis

    • 4.1 Merck Serono
      • 4.1.1 Merck Serono Profiles
      • 4.1.2 Merck Serono Product Information
      • 4.1.3 Merck Serono Follicle Stimulating Hormone Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Merck Serono SWOT Analysis
    • 4.2 MSD
      • 4.2.1 MSD Profiles
      • 4.2.2 MSD Product Information
      • 4.2.3 MSD Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 MSD SWOT Analysis
    • 4.3 IBSA
      • 4.3.1 IBSA Profiles
      • 4.3.2 IBSA Product Information
      • 4.3.3 IBSA Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 IBSA SWOT Analysis
    • 4.4 Ferring
      • 4.4.1 Ferring Profiles
      • 4.4.2 Ferring Product Information
      • 4.4.3 Ferring Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Ferring SWOT Analysis
    • 4.5 Livzon
      • 4.5.1 Livzon Profiles
      • 4.5.2 Livzon Product Information
      • 4.5.3 Livzon Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Livzon SWOT Analysis
    • 4.6 Techwell
      • 4.6.1 Techwell Profiles
      • 4.6.2 Techwell Product Information
      • 4.6.3 Techwell Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Techwell SWOT Analysis
    • 4.7 GenSci
      • 4.7.1 GenSci Profiles
      • 4.7.2 GenSci Product Information
      • 4.7.3 GenSci Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 GenSci SWOT Analysis
    • 4.8 Gedeon Richter
      • 4.8.1 Gedeon Richter Profiles
      • 4.8.2 Gedeon Richter Product Information
      • 4.8.3 Gedeon Richter Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Gedeon Richter SWOT Analysis
    • 4.9 Teva
      • 4.9.1 Teva Profiles
      • 4.9.2 Teva Product Information
      • 4.9.3 Teva Follicle Stimulating HormoneSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Teva SWOT Analysis

    5 Market Performance for Manufacturers

    • 5.1 Global Follicle Stimulating Hormone Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Follicle Stimulating Hormone Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Follicle Stimulating Hormone Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Follicle Stimulating Hormone Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Follicle Stimulating Hormone Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Follicle Stimulating Hormone Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Follicle Stimulating Hormone Market Assessment by Regions (2014-2020)

    • 7.1 Global Follicle Stimulating Hormone Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Follicle Stimulating Hormone Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Follicle Stimulating Hormone Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Follicle Stimulating Hormone Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Follicle Stimulating Hormone Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Infertility Treatment Industry
    • 11.2 Assisted Reproductive Technology Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Follicle Stimulating Hormone Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Follicle Stimulating Hormone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Recombinant FSH
      • 12.2.3 Urinary FSH
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Infertility Treatment
      • 12.3.3 Assisted Reproductive Technology
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Follicle Stimulating Hormone Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Follicle Stimulating Hormone Gross Profit Trend 2021-2026

    13 Conclusion

    Summary:
    Get latest Market Research Reports on Follicle Stimulating Hormone Sales. Industry analysis & Market Report on Follicle Stimulating Hormone Sales is a syndicated market report, published as Global Follicle Stimulating Hormone Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026. It is complete Research Study and Industry Analysis of Follicle Stimulating Hormone Sales market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,650.00
    		$7,200.00
    		2,916.35
    		5,752.80
    		3,416.40
    		6,739.20
    		574,437.00
    		1,133,136.00
    		304,738.50
    		601,128.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo